Issue 27, 2020

TLR2 agonists and their structure–activity relationships

Abstract

Agonists of Toll-like Receptor 2 (TLR2) are attractive synthetic targets due to their use as adjuvants in immunotherapies to treat various diseases notably, cancer. An indepth understanding of TLR2 agonist structure–activity relationships is therefore advantageous for the methodical design of vaccines targetting the TLR2 machinery. This review aims to collate and discuss the literature regarding synthetic studies towards TLR2 agonists and the structure–activity relationships thereof. It is hoped that interested readers will gain a holistic understanding of this topic, and will prompt further efforts towards finding effective agonists of TLR2.

Graphical abstract: TLR2 agonists and their structure–activity relationships

Article information

Article type
Review Article
Submitted
07 میٔ 2020
Accepted
15 جوٗن 2020
First published
19 جوٗن 2020

Org. Biomol. Chem., 2020,18, 5073-5094

TLR2 agonists and their structure–activity relationships

B. L. Lu, G. M. Williams and M. A. Brimble, Org. Biomol. Chem., 2020, 18, 5073 DOI: 10.1039/D0OB00942C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements